Advertisement
U.S. markets closed

Arrowhead Pharmaceuticals, Inc. (ARWR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
28.60-0.10 (-0.35%)
At close: 04:00PM EDT
28.60 0.00 (0.00%)
After hours: 06:58PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Previous Close28.70
Open28.75
Bid28.56 x 400
Ask28.63 x 600
Day's Range28.10 - 29.07
52 Week Range20.67 - 42.48
Volume551,391
Avg. Volume1,639,113
Market Cap3.562B
Beta (5Y Monthly)0.72
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for ARWR

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Arrowhead Pharmaceuticals, Inc.
    ARWR: What does Argus have to say about ARWR?ARROWHEAD PHARMACEUTICALS IN has an Investment Rating of HOLD; a target price of $29.000000; an Industry Subrating of Low; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
    Rating
    Fair Value
    Economic Moat
    2 days agoArgus Research
View more